Member Info for 1509

Eva Nolupus
Now Imm is active again its great to see that the normal banter between you is also back as well.
Much better than watching I'm a celebrity get me out of here.
All the best for the week to come

Hi Bojo
Thanks for your reply, it looks very interesting.
BRH have some interesting investments. Have you come across livecyte? Seems to be an amazing product.
Could you cast your eye over this short video and let me know if you think it has commercial legs
https://www.youtube.com/watch?v=lposS9SNngY

Looking to move some finds out of rms and put the into imm before Avion's meeting with the FDA.
Not a huge amount but if imm dips that could be the opportunity

Morning Eva

Hope fully the share price will remain at this level for me, until we get very close to the meeting.
Looking to hold i few more before the meeting.

all the best

Hi Bojo
I had a look at Parsortix.
Have you looked into whether it could identify covid cells within the blood sample or do you know if Angle are looking to see if it could be developed to detect them

so that's just over 32m shares not in the publics hands.
Did anyone see a sell go though 27m shares was a buyer lined up to take theses?

I agree it could be that it is not clear
So potentially there could be one or an number or people/companies holding that 20%

Honest
Can let us know what your assumptions are

Shares not in public hands: 20.33%
does this include Dr Caves 18.29?
if it does it implies that the public hold just under 80%. This cant be right surely

I get the feeling John is too much into Gyro, not sure he would want to get involved in the politics, he is happy plugging away with Gyro

LP
Thanks

So if this update is effective today then, if there is another significant holder, they have not notified the company which I assume means we will not be getting an rns on Monday about another significant share holder

Hi Bojo
Hope you had a good week. I will give it a go. Having said this I am not watching that may shares so this may be my complete list:-
1 RMS (which other share would it be for me lol) If everything goes to plan short term multi bag. Rns x2 expected on new holder and orders/deals. next 2 weeks is critical for me. If we have a decent spike i think I may reduce, I am too old to hold this roller coaster share.

2 IMM Short term possible bag long term multi bag, all this is critical on FDA approval and successful phase 3

3 IQAI Short term possible bag Artificial imaging is they way forward and this company appears to be cutting adge. Big rns coming up maybe before the end of 2020 about cad free. If validated I can see this going to 50p plus

4 FDBK this is similar to IQAI but for portable devices main product is called Bleepa. if this starts to become standard in the NHS this will multi bag

DNL Slow burner at the moment FDA approval for Alkindi® Sprinkle. Not sure if the market has priced in the potential earnings. Recent placing so the have cash in the bank. This may start to come to life end of Dec, during January.

Hi Troajan
I like your post and agree with what you say.
I think RMS is in a position where on the face of it it has a unique product and until we get an rns about orders we don't know how in demand it is.
If the world is crying out for it then we can kiss goodbye to the current share price and double digits here we come
If there is reasonable demand then surely we are looking at at least 9p
Low demand then around 6p

hi Monkey
I would love to take the rns at face value in which case surely the share would go back up to levels when the rns was released.
The only good guy in this is Dr Cave.
That tweet reinforced what the rns stated and the subsequent interview when he revealed the name of Volz.
RMS and Dr Cave are making all the right noises for their to big some big rns notices on their way.
1 About who has been buying the shares
2 Details on orders
I am not sure if it a good thing, I feel very excited and apprehensive in terms of the anticipation of the notices because any one of them could blow the share price out of the water or have the opposite effect. The information we have leads to the former I think.

Posted this earlier on rms board, it relates to the rns dated 16th November
When the share price has a wobble I like to double check the information I have read.
This rns is very special.
"now anticipates that future demand for its mask may outstrip the production line capacity of five million viricidal face masks per month".
so we can assume that demand is more than 5m per month. It then goes on:-
"To fulfil part of the anticipated excess demand, P2F expects to supply its patented filter material, initially, to certain partner mask manufacturers, until P2F has itself procured additional production lines"
Pay particular attention to "To fulfil part" and "until P2F has itself procured additional production lines"
If we take this rns at face value there is one hell of and order coming in and p2f are lining up to get more machines and manufacture the mask itself to meet the demand.

Ibrox
Thanks
The only thing I didn't like was the use in it of the word "may" but i think this was needed as if the used "will" the the sp would have gone wild.
I am generally cautious but I have to say this rns is very positive

Ibrox
Thank for your post.
How do you read the contents of the rns?

When the share price has a wobble I like to double check the information I have read.
This rns is very special.
"now anticipates that future demand for its mask may outstrip the production line capacity of five million viricidal face masks per month".
so we can assume that demand is more than 5m per month. It then goes on:-
"To fulfil part of the anticipated excess demand, P2F expects to supply its patented filter material, initially, to certain partner mask manufacturers, until P2F has itself procured additional production lines"
Pay particular attention to "To fulfil part" and "until P2F has itself procured additional production lines"
If we take this rns at face value there is one hell of and order coming in and p2f are lining up to get more machines and manufacture the mask itself to meet the demand.

Hi
I was looking at this a week or so ago, from memory the trial was completed around July this year.
My thought is that that the could be an rns on its way with an update on the distribution deal.
The other developing core p2f product is the technology to help citrus greening. The trial started about 6 months ago, it would be nice to have an update